Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2019
|
| _version_ | 1797073404505882624 |
|---|---|
| author | White, NJ |
| author_facet | White, NJ |
| author_sort | White, NJ |
| collection | OXFORD |
| description | Resistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination. |
| first_indexed | 2024-03-06T23:21:38Z |
| format | Journal article |
| id | oxford-uuid:68eb5a69-e747-4e94-90a5-29237c7b98e5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:21:38Z |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:68eb5a69-e747-4e94-90a5-29237c7b98e52022-03-26T18:48:12ZTriple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistanceJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:68eb5a69-e747-4e94-90a5-29237c7b98e5EnglishSymplectic ElementsBioMed Central 2019White, NJResistance threatens all our currently available anti-malarial drugs. Triple artemisinin-containing combination anti-malarial treatments (TACTs) combine an artemisinin derivative with two slowly eliminated partner drugs. TACTs are undergoing large-scale trials. If they prove safe, well-tolerated and efficacious then they should be deployed. This is in order to protect and extend the useful therapeutic life of the current generation of anti-malarial drugs, which are so essential for malaria control and elimination. |
| spellingShingle | White, NJ Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title_full | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title_fullStr | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title_full_unstemmed | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title_short | Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance |
| title_sort | triple artemisinin containing combination anti malarial treatments should be implemented now to delay the emergence of resistance |
| work_keys_str_mv | AT whitenj tripleartemisinincontainingcombinationantimalarialtreatmentsshouldbeimplementednowtodelaytheemergenceofresistance |